DEREK MCDONOUGH: Open Payments
NPI 1245910686 · HANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 51 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $383 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $231 |
| AstraZeneca Pharmaceuticals LP | 7 | $223 |
| Lilly USA, LLC | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Dexcom, Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
Products named: FARXIGA, Wegovy, Rybelsus, Ozempic, AIRSUPRA, VOQUEZNA, JOURNAVX, MOUNJARO.
Industry payments across CA — which companies pay providers there.
